Physician reviewing a tablet with a patient

Dr. R. Mahoney, Pulmonology

14 miles from site 03

✓ Patient enrolled in 2 PAH trials

Clinical

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Ask the map

→

Ask the map

→

Why enrollment stalls

Four in five trials miss their enrollment timeline. The patients exist. The physicians who see them are twenty minutes from the site and have never heard of the study.

Ads find strangers. Patients say they would hear about a trial from their own doctor, not a banner. A screener full of strangers is not enrollment.

So we mapped every US physician: what they treat, where they send patients, where those patients live. Then we do the asking, in your name.

Every effective drug had to be tested in someone. Somewhere in the country, that person already exists and already has a doctor. We are building the layer between the two.

A bright, empty clinic waiting room with sofas and a reception desk

How it works

Share the trial protocol.

Protocol, site addresses, target enrollment. A PDF is enough. The surfacing agent returns the ranked physicians for each site, with the reason each one is on the list.

We find physicians who have your patients.

The outreach agent reaches them by email and phone, in your name. The ask is specific: which of their patients likely qualify and why. Your coordinator joins when a physician is ready.

Patients start enrolling.

Patients arrive at the site the way they always have, with a heads-up before each one. A new list every day: who was reached, who replied, who sent patients, which site needs help next.

No PHI leaves the practice. Spellbinder works at the physician level.

HIPAA compliant. Outreach copy goes through your MLR review.

Nothing to install. Exports to your CTMS on request.

What we built

A map of every US physician and two agents that work it. Nobody on your team builds a list, writes an email or chases a reply.

Healthcare Map

Every US physician, resolved from 400+ sources to one profile: what they treat, whom they send patients to, where those patients live, and which trials they have enrolled into before.

Agents

The surfacing agent reads your protocol and sites and delivers a ranked list per site every morning. The outreach agent runs the conversation in your name, follows up, logs every reply and hands the physician to your coordinator when they say yes.

From protocol to enrolled, in order.

10 physicians identified today

Tap to view your day's targets · 88 miles total

now

Today

7 visits · 88 miles

Dr. Alexandra M Vera

First VisitEarly Adopter

Urology

Memorial Sloan Kettering (18 miles)

Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

First VisitKey Opinion Leader

Internal Medicine

AHF Healthcare Centers (10 miles)

High-volume KOL with exceptional pharma engagement

Dr. Jane Green

First VisitKey Opinion Leader

Internal Medicine — Infectious Disease

Midtown Medical Associates (9 miles)

Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Third VisitKey Opinion Leader

Internal Medicine — Infectious Disease

Bellevue Hospital Center (12 miles)

Follow-up visit — Strong relationship, expand product discussion

What is on the map

Every physician, for any indication.Especially the rare ones.

For every disease, the doctors who treat it and the ones nobody has asked yet.

Type 2 diabetes (GLP-1)

144,800 prescribing

61,900 outside the trial record

Alzheimer's and related dementias

121,800 treating

38,300 outside the trial record

Migraine

91,100 treating

6,500 outside the trial record

Heart failure

55,000 treating

15,500 outside the trial record

Schizophrenia

21,800 treating

2,100 outside the trial record

ATTR amyloidosis

1,900+ treating

190 outside the trial record

Pulmonary arterial hypertension

3,186 treating

252 outside the trial record

Breast cancer

10,300 treating

3,700 outside the trial record

Pulmonary fibrosis

5,815 treating

1,159 outside the trial record

Primary biliary cholangitis

4,800 treating

76,220 share patients

Geographic atrophy

2,800 treating

26,427 share patients

Hereditary angioedema

2,400 treating

7,876 share patients

ALS

1,315 treating

28,593 share patients

Cystic fibrosis

869 treating or researching

11,695 share patients

Spinal muscular atrophy

671 treating

8,026 share patients

+ 3,863 more diseases on the map

Common: shortlist at 10+ patients a yearSpecialty: shortlist at 5+ patients a yearRare: every treating physician, and the physicians who share their patients

Physician counts. Patient volumes are predicted.

83%

of patients identified were interested and sent to the site, because the ask came from their own physician, not an ad.

107 patients identified

One CNS trial, still ramping

89 interested and sent to the site18 declined

Trusted by experts at pharmaceutical companies

“Our coordinators had spent a month finding one physician. Spellbinder gave us three in forty-eight hours. We signed before the contract was drafted.”

Clinical Operations Lead

One healthcare map
for biopharma and healthtech.

The same physician profiles, care patterns and outreach engine serve the clinical team filling a trial, the commercial team preparing a launch and the healthtech company selling to providers.

Dr. Alexandra M Vera

Urology · Investigator

Matched

Trials near her patients

Overactive bladder · Phase 34.2 mi38 eligible
BPH device study · Phase 26.8 mi21 eligible
Prostate cancer · Phase 39.1 mi17 eligible

Clinical